Mounjaro's Sales Likely To Rise 2.5x Driving Eli Lilly's Q3 Performance
The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the ...
Reuters1d
Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News
The drugmaker has received approval from the Hong Kong government to sell its tirzepatide injections — branded as Mounjaro ...
Eli Lilly tells Bloomberg approval received to launch Mounjaro in Hong Kong
Eli Lilly (LLY) expects to start selling its weight-loss drug tirzepatide, branded as Mounjaro, in Hong Kong as early as the ...
Eli Lilly Q3 2024 Earnings Preview: Focus on exit rate, fear of revenue miss on the horizon
Over the last 3 months, EPS estimates have seen 0 upward revisions and 13 downward. Revenue estimates have seen 16 upward ...
Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains (CORRECTED)
Eli Lilly reports Q3 earnings on Wednesday. Stock up 58% in past year, potential to split to attract investors in growing ...
EconoTimes2d
Eli Lilly Set to Launch Weight-Loss Drug Mounjaro in Hong Kong by Year-End
Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End Global pharmaceutical giant Eli Lilly is gearing up ...
Eli Lilly Q3 earnings expected to beat Wall Street expectations
Eli Lilly is set to report Q3 earnings Wednesday, as the pharma giant continues to gain market share in the weight loss drug ...
Eli Lilly Gets Nod to Launch Blockbuster Weight-Loss Drug in Hong Kong
Eli Lilly & Co. expects to start selling its highly popular weight-loss drug in Hong Kong as early as the end of this year, ...
GHP Investment Advisors Inc. Has $1.64 Million Position in Eli Lilly and Company (NYSE:LLY)
GHP Investment Advisors Inc. lifted its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 5.1% during the third ...